Literature DB >> 21947348

Herpes zoster infection, vaccination and immunocompromised rheumatology patients.

Mortimer B O'Connor1, Mark J Phelan.   

Abstract

Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947348     DOI: 10.1007/s00296-011-2155-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  7 in total

1.  Development of a live attenuated varicella vaccine.

Authors:  M Takahashi; Y Okuno; T Otsuka; J Osame; A Takamizawa
Journal:  Biken J       Date:  1975-03

Review 2.  Economic evaluations of varicella vaccination programmes: a review of the literature.

Authors:  Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

Authors:  M Brisson; W J Edmunds; N J Gay
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

4.  Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases.

Authors: 
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

5.  Modelling the impact of immunization on the epidemiology of varicella zoster virus.

Authors:  M Brisson; W J Edmunds; N J Gay; B Law; G De Serres
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

6.  The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.

Authors:  Mark Quinlivan; Khidir Hawrami; Winsome Barrett-Muir; Peter Aaby; Ann Arvin; Vincent T Chow; T Jacob John; Patrick Matondo; Malik Peiris; Anja Poulsen; Marilda Siqueira; Michiaki Takahashi; Yamima Talukder; Koichi Yamanishi; Mary Leedham-Green; Fiona T Scott; Sara L Thomas; Judith Breuer
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

7.  Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.

Authors:  Sara L Thomas; Jeremy G Wheeler; Andrew J Hall
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.